Dr Jilong Qin

Find Jilong Qin on

Recent tweets

Postdoctoral Fellow

PhD (University of Adelaide)

Dr. Jilong Qin acquired his PhD at the University of Adelaide in 2020, where he worked on bacterial surface virulence factors including type 3 secretion system, autotransporters and lipopolysaccharides using Shigella flexneri as a model organism. He then joined Queensland University of Technology in 2020 as a postdoctoral research fellow working on bacterial adhesins in UPEC with A/prof Makrina Totsika. He has a strong interest in bacterial virulence factors and their molecular mechanisms in bacterial pathogenesis. He recently worked on improvement of DNA delivery in pathogenic Gram-negative pathogens, adhesin protein allosteric mechanisms and protein conformational heterogeneity.

Publications

  1. UV-driven microvalve based on a micro–nano TiO2/SiO2 composite surface for microscale flow control (2014), T Guo, T Meng, W Li, J Qin, Z Tong, Q Zhang, X Li, Nanotechnology 25 (12), 125301
  2. The virulence domain of Shigella IcsA contains a subregion with specific host cell adhesion function (2020), J Qin, MT Doyle, ENH Tran, R Morona, PloS one 15 (1), e0227425
  3. Interdependence of Shigella flexneri O Antigen and Enterobacterial Common Antigen Biosynthetic Pathways (2022), N Maczuga, ENH Tran, J Qin, R Morona, Journal of Bacteriology 204 (4), e00546-21
  4. Co-Occurrence of Multidrug Resistant Klebsiella pneumoniae Pathogenic Clones of Human Relevance in an Equine Pneumonia Case (2022), Venturini C, Bowring B, Partridge SR, Ben Zakour NL, Fajardo-Lubian A, Lopez Ayala A, Qin J, Totsika M, van Galen G, Norris J, Iredell J. Microbiology Spectrum, e02158-21
  5. Development of 3D Printed Biodegradable Mesh with Antimicrobial Properties for Pelvic Organ Prolapse (2022) Ren J, Murray R, Wong CS, Qin J, Chen M, Totsika M, Riddell AD, Warwick A, Rukin N, Woodruff MA. Polymers. 2022 Feb 16;14(4):763.
  6. Loss of β-Ketoacyl Acyl Carrier Protein Synthase III Activity Restores Multidrug-Resistant Escherichia coli Sensitivity to Previously Ineffective Antibiotics. (2022) Hong Y, Qin J, Verderosa A, Hawas S, Zhang B, Blaskovich MA, Cronan JE, Totsika M. mSphere. 2022 May 16.
  7. A method for increasing electroporation competency of Gram-negative clinical isolates by Polymyxin B nonapeptide. (2022) Qin J, Hong Y, Pullela K, Morona R, Henderson IR, Totsika M. Sci Rep 12, 11629.